# Stiefel, a GSK Company clinical trials: 56

ClinicalTrials.gov lists 56 trials with Stiefel, a GSK Company as lead sponsor, 0 of them recruiting or not yet recruiting.

## The full list

Clinical trials led by Stiefel, a GSK Company: 56 rows for $5, every trial on ClinicalTrials.gov. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/stiefel-a-gsk-company

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 56
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 56, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| February 4, 2016 | NCT02673619 | A Study to Evaluate Clinical Effect, Pharmacokinetics , Safety, and Tolerability of Umeclidinium in Palmar Hyperhidrosis Subjects | Stiefel, a GSK Company | Phase 2 | Completed | Hyperhidrosis | 58 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02673619) |
| August 17, 2015 | NCT02524665 | 8 Week Study to Evaluate and Compare the Efficacy and Tolerability of MAXCLARITY II and MURAD To Treat Acne | Stiefel, a GSK Company | Phase 4 | Completed | Acne Vulgaris | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02524665) |
| April 8, 2015 | NCT02411162 | A Single Dose Phase I Exploratory Study in Healthy Volunteers With GSK2894512 Cream | Stiefel, a GSK Company | Phase 1 | Completed | Dermatitis, Atopic | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02411162) |
| December 18, 2013 | NCT02014584 | Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia | Stiefel, a GSK Company | Phase 3 | Completed | Alopecia | 117 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02014584) |
| November 15, 2013 | NCT01984775 | A Study to Evaluate the Irritation Potential of GSK2894512 Cream on Skin in Healthy Subjects | Stiefel, a GSK Company | Phase 1 | Completed | Psoriasis | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01984775) |
| August 27, 2013 | NCT01929278 | W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential... | Stiefel, a GSK Company | Phase 1 | Completed | Acne Vulgaris | 37 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01929278) |
| October 15, 2012 | NCT01706263 | U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With Acne | Stiefel, a GSK Company | Phase 4 | Completed | Acne Vulgaris | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01706263) |
| October 15, 2012 | NCT01706250 | U0289-401: Eight Week, Split-face, Study to Determine and Compare the Efficacy and Tolerability of MAXCLARITY™ II to PROACTIV™ | Stiefel, a GSK Company | Phase 4 | Completed | Acne Vulgaris | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01706250) |
| October 5, 2011 | NCT01446237 | U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%)... | Stiefel, a GSK Company | Not applicable | Completed | Acne Vulgaris | 125 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01446237) |
| March 25, 2011 | NCT01323673 | Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis. | Stiefel, a GSK Company | Phase 4 | Completed | Dermatitis, Chronic | 125 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01323673) |
| November 22, 2010 | NCT01245140 | Efficacy of Alitretinoin Treatment in Patients With Pustular Form of Psoriasis | Stiefel, a GSK Company | Phase 2 | Completed | Psoriasis | 33 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01245140) |
| June 8, 2010 | NCT01139580 | The Purpose of This Study is to Demonstrate the Safety and Effectiveness of Calcipotriene Foam in Subjects With Scalp and Body Psoriasis | Stiefel, a GSK Company | Phase 3 | Completed | Psoriasis | 363 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01139580) |
| May 28, 2010 | NCT01132443 | W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin... | Stiefel, a GSK Company | Phase 1 | Completed | Acne Vulgaris | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01132443) |
| May 7, 2010 | NCT01119651 | A Study to Evaluate the Potential of Tazarotene Foam to Cause an Allergic Reaction When Applied to the Skin and Exposed to Light on Healthy... | Stiefel, a GSK Company | Phase 1 | Completed | Acne Vulgaris | 59 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01119651) |
| May 4, 2010 | NCT01115322 | A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers | Stiefel, a GSK Company | Phase 1 | Completed | Acne Vulgaris | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01115322) |
| May 3, 2010 | NCT01114841 | A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy Volunteers | Stiefel, a GSK Company | Phase 1 | Completed | Acne Vulgaris | 254 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01114841) |
| April 28, 2010 | NCT01112787 | A Study to Evaluate the Irritation Potential of Tazarotene Foam on Skin in Healthy Volunteers | Stiefel, a GSK Company | Phase 1 | Completed | Acne Vulgaris | 39 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01112787) |
| December 25, 2009 | NCT01039883 | A Study to Compare the Blood Levels of Albaconazole in Healthy Subjects Who Have Received a Single Dose of 400 mg Albaconazole as a Tablet... | Stiefel, a GSK Company | Phase 1 | Completed | Onychomycosis | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01039883) |
| November 25, 2009 | NCT01019603 | A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne Vulgaris | Stiefel, a GSK Company | Phase 1 | Completed | Acne Vulgaris | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01019603) |
| November 20, 2009 | NCT01017146 | A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - W0260-301 | Stiefel, a GSK Company | Phase 3 | Completed | Acne Vulgaris | 744 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01017146) |
| November 20, 2009 | NCT01017120 | A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne | Stiefel, a GSK Company | Phase 3 | Completed | Acne Vulgaris | 742 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01017120) |
| November 20, 2009 | NCT01016977 | A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With... | Stiefel, a GSK Company | Phase 4 | Completed | Acne Vulgaris | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01016977) |
| November 18, 2009 | NCT01015638 | Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications | Stiefel, a GSK Company | Phase 4 | Completed | Acne Vulgaris | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01015638) |
| November 17, 2009 | NCT01014962 | A Study of the Effects of Increasing Doses of a Drug for the Treatment of Nail Fungus | Stiefel, a GSK Company | Phase 1 | Completed | Onychomycosis | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01014962) |
| August 24, 2009 | NCT00964366 | Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications | Stiefel, a GSK Company | Phase 4 | Completed | Acne Vulgaris | 53 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00964366) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 14 |
| Phase 2 | 7 |
| Phase 2/3 | 1 |
| Phase 3 | 12 |
| Phase 4 | 21 |
| Not applicable | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 55 |
| Withdrawn | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Acne Vulgaris | 29 |
| Psoriasis | 10 |
| Dermatitis | 4 |
| Onychomycosis | 4 |
| Dermatitis, Phototoxic | 1 |
| Dermatitis, Seborrheic | 1 |
| Cellulitis | 1 |
| Impetigo | 1 |
| Dermatitis, Atopic | 1 |
| Bronchiolitis Obliterans Syndrome | 1 |
| Hand Dermatoses | 1 |
| Skin Diseases | 1 |
| Alopecia | 1 |
| Eczema | 1 |
| Eczema, Dyshidrotic | 1 |
| Diaper Rash | 1 |
| Tinea Pedis | 1 |
| Hyperhidrosis | 1 |
| Ichthyosis, Lamellar | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Fastener suppliers in the United States](https://specstream.ai/data/businesses/fastener-suppliers/united-states)
- [Public health clinics in the United States](https://specstream.ai/data/businesses/public-health-clinics/united-states)
- [Builders in the United States](https://specstream.ai/data/businesses/builders/united-states)
- [Landscape architecture firms in the United States](https://specstream.ai/data/businesses/landscape-architecture-firms/united-states)
- [Urology practices in the United States](https://specstream.ai/data/businesses/urology-practices/united-states)
- [Endocrinology practices in the United States](https://specstream.ai/data/businesses/endocrinology-practices/united-states)
